One in Six Cancer Medications Fails Safety Standards in Sub-Saharan Africa

One in six cancer medications fails safety standards in sub-Saharan Africa

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

‘It’s heartbreaking’: bad cancer drugs shipped to more than 100 countries

Around one fifth of generic cancer medication samples tested by the University of Notre Dame fail quality tests.

Chemotherapy drugs made by Indian firms fail quality tests, shows study

A landmark study published on June 26 has reported that about a fifth of cancer drugs tested failed quality tests; 16 of the 17 implicated manufacturers are India-based

Generic cancer drugs used around the world fail quality tests, investigation shows

Investigation finds too little or too much active ingredient in about a fifth of all chemotherapy samples; patients in 100 countries at risk

In sub-Saharan Africa, 1 in 6 cancer medications found to be defective

Serious quality defects were found in a significant number of cancer medications from sub-Saharan Africa, according to new research from the University of Notre Dame.

Substandard cancer drugs supplied to over 100 countries including Pakistan

A new study has revealed that over 100 countries, including Pakistan, have been supplied with substandard cancer medications that not only proved ineffective but, in some cases, were found to be harmful to health. An investigative report has caused global alarm by disclosing that critical chemotherapy drugs, used in the treatment of various types of cancer, were exported to more than 100 countries without meeting established quality standards. T…